Cargando…

Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis

OBJECTIVE: To systematically evaluate the clinical efficacy and safety of Shenkang injection (SKI) combined with alprostadil in the treatment of chronic renal failure (CRF). METHOD: Randomized controlled trials (RCTs) of Shenkang injection combined with alprostadil in CRF treatment were investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Feng, Zhang, Tiantian, Zhang, Pu, Qu, Xinliang, Li, Min, Lan, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118024/ https://www.ncbi.nlm.nih.gov/pubmed/37089596 http://dx.doi.org/10.3389/fmed.2023.982016

Ejemplares similares

Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats
por: Chen, Rongchang, et al.
Publicado: (2022)

Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial
por: Mei, JuXiang, et al.
Publicado: (2021)

Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology—Molecular docking—Key target validation"
por: Zhou, Lin, et al.
Publicado: (2023)

Shenkang protects renal function in diabetic rats by preserving nephrin expression
por: Qu, Zhihui, et al.
Publicado: (2023)

ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
por: Wei, Hui-Ting, et al.
Publicado: (2022)

Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein
por: Zhu, Jianhua, et al.
Publicado: (2022)

Efficacy and safety of Shenkang injection as adjuvant therapy in patients with diabetic nephropathy: A protocol for systematic review and meta-analysis
por: Wang, Yanping, et al.
Publicado: (2020)

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
por: Luo, Liang-Pu, et al.
Publicado: (2021)

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017)

Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy
por: Wang, Wen-Wen, et al.
Publicado: (2021)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction
por: Zou, Junju, et al.
Publicado: (2022)

Pharmacokinetics and Metabolism Research of Shenkang Injection in Rats Based on UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS
por: Jiang, Xiaofang, et al.
Publicado: (2020)

Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy
por: Hong, Yan, et al.
Publicado: (2017)

Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway
por: Qin, Tianyu, et al.
Publicado: (2021)

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
por: Jung, Seung Mook
Publicado: (2019)

Alprostadil vs. isosorbide dinitrate in ameliorating angina episodes in patients with coronary slow flow phenomenon: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2022)

Author Correction: Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2019)

Effect of alprostadil in the treatment of intensive care unit patients with acute renal injury
por: Jia, Yan, et al.
Publicado: (2021)

Shenkang Injection protects against diabetic nephropathy in streptozotocin (STZ)-induced mice through enhancement of anti-oxidant and anti-inflammatory activities
por: Zhang, Bin, et al.
Publicado: (2020)

Clinical evaluation of Alprostadil combined with Nimodipine in treatment of Cerebral Vasospasm after Subarachnoid Hemorrhage in elderly patients
por: Liu, Sisi, et al.
Publicado: (2023)

Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials
por: Fu, Hongfang, et al.
Publicado: (2022)

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019)

Guanxinning Injection Combined With Ischemic Postconditioning Attenuate Myocardial Ischemic Reperfusion Injury in Chronic Renal Failure Rats by Modulating Mitochondrial Dynamics
por: Wang, Anzhu, et al.
Publicado: (2022)

Is It Worth Continuing Sexual Rehabilitation after Radical Prostatectomy with Intracavernous Injection of Alprostadil for More than 1 Year?
por: Yiou, René, et al.
Publicado: (2015)

Alprostadil/papaverine/phentolamine: Delayed infected lymphocele: case report
Publicado: (2021)

The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis
por: Guan, Hailian, et al.
Publicado: (2020)

Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia–reperfusion injury in rats
por: Erer, Dilek, et al.
Publicado: (2016)

Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere
por: Luo, Yuling, et al.
Publicado: (2022)

Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
por: XU, RONG-HE, et al.
Publicado: (2013)

Tratamiento con alprostadil en el paciente diabético con impotencia sexual
por: Castillo Rodríguez, Jorge
Publicado: (1998)

Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review
por: Anaissie, James, et al.
Publicado: (2016)

The protective effect of Papaverine and Alprostadil in rat testes after ischemia and reperfusion injury
por: Karagoz, Mehmet Ali, et al.
Publicado: (2018)

DIC Score Combined With CLIF-C OF Score Is More Effective in Predicting Prognosis in Patients With Hepatitis B Virus Acute-on-Chronic Liver Failure
por: Zhang, Xueyun, et al.
Publicado: (2022)

Effects of alprostadil combined with hyperbaric oxygen on hearing recovery and hemorheology in patients with sudden sensorineural hearing loss and analysis of related influencing factors
por: Feng, Tao, et al.
Publicado: (2022)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

Citalopram in the treatment of elderly chronic heart failure combined with depression: A systematic review and meta-analysis
por: Yan, Longmei, et al.
Publicado: (2023)

Liver transplantation in Acute-on-Chronic liver failure: Timing of transplantation and selection of patient population
por: Li, Xue, et al.
Publicado: (2022)

How effective are alprostadil and hydrocortisone on reperfusion injury in kidney after distant organ ischemia?
por: Ebrahimi, Ali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_scnllvvumu85ck3ngk6vl3pjd4